Richard J Bende Selected Research

Immunoglobulin G (IgG)

1/2020	Salivary Gland Mucosa-Associated Lymphoid Tissue-Type Lymphoma From Sjögren's Syndrome Patients in the Majority Express Rheumatoid Factors Affinity-Selected for IgG.
4/2015	Stereotypic rheumatoid factors that are frequently expressed in mucosa-associated lymphoid tissue-type lymphomas are rare in the labial salivary glands of patients with Sjögren's syndrome.
4/2005	Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity.
3/2002	In situ analysis of the variable heavy chain gene of an IgM/IgG-expressing follicular lymphoma: evidence for interfollicular trafficking of tumor cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard J Bende Research Topics

Disease

6	Lymphoma (Lymphomas) 01/2023 - 01/2003
6	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020 - 07/2006
5	Neoplasms (Cancer) 01/2023 - 03/2002
5	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2020 - 04/2005
4	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2016 - 01/2002
2	Leukemia 01/2020 - 01/2019
2	Autoimmune Diseases (Autoimmune Disease) 01/2010 - 08/2009
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 07/2006 - 04/2005
1	Multiple Myeloma 01/2020
1	Ataxia Telangiectasia (Louis Bar Syndrome) 10/2016
1	Genomic Instability 09/2015
1	Hodgkin Disease (Hodgkin's Disease) 05/2008
1	Autoimmune Polyendocrinopathies (Schmidt Syndrome) 11/2007
1	Thymoma (Thymic Carcinoma) 11/2007
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 04/2005
1	Nephritis 03/2001
1	Glomerulonephritis 03/2001
1	Fibrosis (Cirrhosis) 03/2001

Drug/Important Bio-Agent (IBA)

5	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 01/2003
4	Immunoglobulin G (IgG)IBA 01/2020 - 03/2002
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2002
3	AntibodiesIBA 01/2020 - 04/2005
3	Phosphotransferases (Kinase)IBA 01/2020 - 10/2016
3	Rheumatoid FactorIBA 01/2016 - 04/2005
3	Cytidine DeaminaseIBA 07/2006 - 07/2003
2	EnzymesIBA 01/2023 - 01/2019
2	AutoantigensIBA 01/2020 - 11/2007
2	Immunoglobulin M (IgM)IBA 01/2020 - 03/2002
2	B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA 01/2020 - 04/2005
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 11/2007
2	AntigensIBA 01/2010 - 01/2003
2	Antigen Receptors (Antigen Receptor)IBA 07/2006 - 04/2005
2	DNA (Deoxyribonucleic Acid)IBA 07/2003 - 01/2002
2	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2003 - 01/2002
1	ibrutinibIBA 01/2023
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2020
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 01/2019
1	Imatinib Mesylate (Gleevec)FDA Link 01/2019
1	pevonedistatIBA 01/2019
1	Surrogate Immunoglobulin Light ChainsIBA 12/2016
1	EndonucleasesIBA 09/2015
1	LigandsIBA 01/2013
1	AutoantibodiesIBA 01/2010
1	ChemokinesIBA 08/2009
1	interleukin-21 (interleukin 21)IBA 05/2008
1	Amino Acids FDA Link 04/2005
1	AS 8IBA 04/2005
1	Chemokine ReceptorsIBA 01/2003
1	Immunoglobulin A (IgA)IBA 01/2003
1	IntegrinsIBA 01/2003
1	Immunoglobulin IsotypesIBA 01/2003
1	Messenger RNA (mRNA)IBA 03/2001
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 03/2001
1	Connective Tissue Growth FactorIBA 03/2001

Therapy/Procedure

2	Therapeutics 01/2023 - 01/2020
1	Lasers (Laser) 03/2002